IMPROVED CIPROFLOXACIN PENETRATION IN GOAT EYES USING COMPLEXATION TECHNIQUE

  • DURGA PANDEY Department of Pharmaceutics, School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, Madhya Pradesh, India.
  • DEEPTI JAIN Department of Pharmaceutics, School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, Madhya Pradesh, India.

Abstract

Objective: The objective of the present work was to improve the retention and penetration of ciprofloxacin (CF) ion pair entrapped within submicron emulsion (SE) in goat eyes and characterize the SE for improvement of ocular activity. The developed delivery system resulted with prolonged drug release as compared to the conventional dosage form.


Methods: SE prepared by high-energy emulsification and sonication to obtain uniform globule size. Ion-pair complex is prepared by precipitation method.


Results: Average internal droplets size of the optimized formulation was 0.300 μm, pH of the optimized formulation was 6.4±0.7 (average of three determinations) and viscosity 3.2±0.3 cP suitable for ocular use. Entrapment was 92.12%. In vitro drug release pattern in dialysis membrane showed sustain release of CF, a cumulative percent release of CF was found 77% in 10 h. Scanning electron microscopy showed spherical shape and size within 1 μm. In vitro release in goat eyes was found 35.86 % for optimized formulation compared to market, 26.83% in 60 min.


Conclusion: Developed optimized formulation can be a good candidate for ocular drug delivery in severe ocular infections where frequent dosing required such as endophthalmitis, corneal ulcer, and penetrating trauma.

Keywords: Ocular, Submicron emulsion, Ion-pair complex, Prolonged drug release, Ciprofloxacin

Author Biography

DURGA PANDEY, Department of Pharmaceutics, School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, Madhya Pradesh, India.

Higher education-Mpharm

Research Scholar, School of pharmaceutical sciences, RGPV Bhopal.

Area of interest- Novel drug delivery system.

References

1. Del Amo EM, Rimpelä AK, Heikkinen E, Kari OK, Ramsay E, Lajunen T, et al. Pharmacokinetic aspects of retinal drug delivery. Prog Retin Eye Res 2017;57:134-85.
2. Ramesh Y, Kothapalli CB, Reddigari JR. A novel approach on ocular drug delivery. J Drug Deliv Ther 2017;7:117-24.
3. Taskar P, Tatke A, Majumdar S. Advances in the use of prodrugs for drug delivery to the eye. Expert Opin Drug Deliv 2017;14:49-63.
4. Mahor A, Prajapati SK, Verma A, Gupta R, Iyer AK, Kesharwani P, et al. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in vivo evaluation. J Colloid Interface Sci 2016;483:132-8.
5. Brannigan RP, Khutoryanskiy VV. Synthesis and evaluation of mucoadhesive acryloyl-quaternized PDMAEMA nanogels for ocular drug delivery. Colloids Surf B Biointerfaces 2017;155:538-43.
6. Romero GB, Keck CM, Müller RH, Bou-Chacra NA. Development of cationic nanocrystals for ocular delivery. Eur J Pharm Biopharm 2016;107:215-22.
7. Cao Y, Zhang C, Shen W, Cheng Z, Yu LL, Ping Q, et al. Poly(N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release 2007;120:186-94.
8. Mealy JE, Fedorchak MV, Little SR. In vitro characterization of a controlled-release ocular insert for delivery of brimonidine tartrate. Acta Biomater 2014;10:87-93.
9. Singh Y, Meher JG, Raval K, Khan FA, Chaurasia M, Jain NK, et al. Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release 2017;252:28-49.
10. Sharma A, Taniguchi J. Review: Emerging strategies for antimicrobial drug delivery to the ocular surface: Implications for infectious keratitis. Ocul Surf 2017;15:670-9.
11. Solans C, Izquierdo PJ, Nolla J, Azemar N, Garcia-Celma MJ. Nano-emulsions current opinion in colloid and interface science. J Colloid Interface Sci 2005;10:102-10.
12. Tamilvanan S, Benita S. The potential of lipid emulsion for ocular delivery of lipophilic drugs. Eur J Pharm Biopharm 2004;58:357-68.
13. Sari F, Sinaga KR, Donald S. Formulation and evaluation of red palm olein nanoemulsion. Asian J Pharm Clin Res 2018;11:237-40.
14. Khiljee T, Akhtar N. Development and in vitro evaluation of a new topical o/w Emulgel from fruit extract of Pyrus communis. Int J Pharm Pham Sci 2019;11:75-9.
15. Hingorani T, Gul W, Elsohly M, Repka MA, Majumdar S. Effect of ion pairing on in vitro transcorneal permeability of a ?(9) tetrahydrocannabinol prodrug: Potential in glaucoma therapy. J Pharm Sci 2012;101:616-26.
16. Higashiyama M, Tajika T, Inada K. Improvement of the ocular bioavailability of timolol by sorbic acid. J Ocul Pharmacol Ther 2006;22:333-9.
17. Zhigaltsev IV, Maurer N, Edwards K, Karlsson G, Cullis PR. Formation of drug-arylsulfonate complexes inside liposomes: A novel approach to improve drug retention. J Control Release 2006;110:378-86.
18. Uivarosi V. Metal complexes of quinolone antibiotics and their applications: An update. Molecules 2013;18:11153-97.
19. Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006;314:72-82.
20. Ravikumar S, Krishnan RG, Selvanathan K, Selvam S. Antibacterial activity of metal oxide nanoparticles against ophthalmic pathogen. Int J Pharm Res Dev 2011;3:122-7.
21. Jena SK, Singh C, Dora CP, Suresh S. Development of tamoxifen-phospholipid complex: Novel approach for improving solubility and bioavailability. Int J Pharm 2014;473:1-9.
22. Devrim B, Bozkir A. Design and evaluation of hydrophobic ion pairing complexation of lysozyme with sodium dodecyl sulphate for improved encapsulation of hydrophilic peptides/protein by lipid-polymer hybrid nanoparticles. J Nanomed Nanotechnol 2015;6:1-5.
23. Ellbogen MH, Olsen KM, Gentry-Nielsen MJ, Preheim LC. Efficacy of liposome-encapsulated ciprofloxacin compared with ciprofloxacin and ceftriaxone in a rat model of pneumococcal pneumonia. J Antimicrob Chemother 2003;51:83-91.
24. Loftsson T, Brewster ME. Cyclodextrins as functional excipients: Methods to enhance complexation efficiency. J Pharm Sci 2012;101:3019-32.
25. Leong TS, Wooster TJ, Kentish SE, Ashokkumar M. Minimising oil droplet size using ultrasonic emulsification. Ultrason Sonochem 2009;16:721-7.
26. Yasir M, Sara UV. Solid lipid nanoparticles for nose to brain delivery of haloperidol: In vitro drug release and pharmacokinetics evaluation. Acta Pharm Sin B 2014;4:454-63.
27. NCCLS. National Committee for Clinical laboratory Standard Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. 5th ed. Villanova, PA, USA: NCCLS, (Approved Standard M-7A5); 2000.
28. Li J, Tan G, Cheng B, Liu D, Pan W. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Eur J Pharm Biopharm 2017;120:89-97.
29. Jafari SM, He Y, Bhandari B. Nanoemulsion production by sonication and microfluidization a comparison. Int J Food Properties 2006;9:475 85.
30. Oyedele AO, John OO, Ogungbemi HO, Olateju SO. Ocular tolerance and in vitro release of chloramphenicol in prospective eye ointment bases. Int J Pharm Pharm Sci 2015;7:306-11.
31. Kandav G, Bhatt D, Jindal DK. Formulation and evaluation of allopurinol loaded chitosan nanoparticles. Int J Appl Pharm 2019;11:49 52.
Statistics
133 Views | 40 Downloads
How to Cite
DURGA PANDEY, and DEEPTI JAIN. “IMPROVED CIPROFLOXACIN PENETRATION IN GOAT EYES USING COMPLEXATION TECHNIQUE”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 8, June 2019, pp. 168-71, https://innovareacademics.in/journals/index.php/ajpcr/article/view/33890.
Section
Original Article(s)